KPT-330,Selinexor

≥99.5%

  • Product Code: 66616
  Alias:    Seliniso
  CAS:    1393477-72-9
Molecular Weight: 443.31 g./mol Molecular Formula: C₁₇H₁₁F₆N₇O
EC Number: MDL Number: MFCD27987944
Melting Point: Boiling Point:
Density: Storage Condition: -20℃
Product Description: KPT-330, also known as Selinexor, is primarily used in the treatment of certain types of cancer. It is particularly effective in treating multiple myeloma and diffuse large B-cell lymphoma, especially in cases where other treatments have failed. Selinexor works by inhibiting the exportin 1 (XPO1) protein, which is responsible for transporting tumor suppressor proteins out of the cell nucleus. By blocking this process, Selinexor helps to accumulate these tumor suppressor proteins in the nucleus, leading to cancer cell death. This mechanism makes it a valuable option for patients with relapsed or refractory cancers. Additionally, ongoing research is exploring its potential in treating other malignancies, including solid tumors and hematologic cancers. The drug is typically administered orally, making it convenient for outpatient treatment. However, it is often associated with side effects such as nausea, fatigue, and low blood counts, which require careful management. Despite these challenges, Selinexor represents a significant advancement in targeted cancer therapy, offering hope to patients with limited treatment options.
Product Specification:
Test Specification
APPEARANCE White to Yellow solid
PURITY 99.5-100
Infrared spectrum Conforms to Structure
NMR Conforms to Structure
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days ฿7,370.00
+
-
0.025 10-20 days ฿22,120.00
+
-
0.100 10-20 days ฿51,080.00
+
-
0.250 10-20 days ฿99,850.00
+
-
KPT-330,Selinexor
KPT-330, also known as Selinexor, is primarily used in the treatment of certain types of cancer. It is particularly effective in treating multiple myeloma and diffuse large B-cell lymphoma, especially in cases where other treatments have failed. Selinexor works by inhibiting the exportin 1 (XPO1) protein, which is responsible for transporting tumor suppressor proteins out of the cell nucleus. By blocking this process, Selinexor helps to accumulate these tumor suppressor proteins in the nucleus, leading to cancer cell death. This mechanism makes it a valuable option for patients with relapsed or refractory cancers. Additionally, ongoing research is exploring its potential in treating other malignancies, including solid tumors and hematologic cancers. The drug is typically administered orally, making it convenient for outpatient treatment. However, it is often associated with side effects such as nausea, fatigue, and low blood counts, which require careful management. Despite these challenges, Selinexor represents a significant advancement in targeted cancer therapy, offering hope to patients with limited treatment options.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page